Cellular Origins has successfully shown that its platform is able to fully automate cell therapy manufacturing processes using validated, off-the-shelf third-party instruments in combination with mobile robots and Cellular Origins’ proprietary sterile fluid transfer technology. As a next step, Cellular Origins is developing its first end-to-end, GMP-ready system for clinical manufacturing.
